title: Impact of nutritional supplementation on immune response, body mass index and bioelectrical impedance in HIV-positive patients starting antiretroviral therapy.
abstract: BACKGROUND
  Challenges to HIV care in resource limited settings (RLS) include malnutrition. Limited evidence supports the benefit of nutritional supplementation when starting antiretroviral therapy (ART) in RLS.
  
  
  METHODS
  Randomized controlled pilot study. HIV-positive ART-naive adults with self-reported weight loss were randomized to receive ART plus FutureLife porridge nutritional supplement (NS) (388 kcal/day) or ART alone (Controls) for 6 months. Patients returned for monthly assessments and blood was drawn at enrolment and 6 months on ART. Differences in body composition, biochemical and laboratory parameters were estimated at 6 months on treatment.
  
  
  RESULTS
  Of the 36 randomized patients, 26 completed the 6 month follow-up (11 NS vs 15 Controls). At enrolment, groups were similar in terms of age, gender, body mass index (BMI) and bioelectrical impedance. NS patients had a lower median CD4 count (60 cells/mm3 [IQR 12-105 vs. 107 cells/mm3 [IQR 63-165]; p = 0.149) and hemoglobin (10.3 g/dL [IQR 9.0-11.3] vs. 13.1 g/dL [IQR 11.1-14.7]; p = 0.001).
  
  
  CONCLUSIONS
  Preliminary results are encouraging and suggest that NS taken concurrently with ART can promote weight gain, improve immune response and improve physical activity in HIV-positive patients that present at ART initiation with weight loss.
authors.forename: Denise
authors.initials: D
authors.lastname: Evans
authors.forename: Lynne
authors.initials: L
authors.lastname: McNamara
authors.forename: Mhairi
authors.initials: M
authors.lastname: Maskew
authors.forename: Katerina
authors.initials: K
authors.lastname: Selibas
authors.forename: Desiree
authors.initials: D
authors.lastname: van Amsterdam
authors.forename: Nicola
authors.initials: N
authors.lastname: Baines
authors.forename: Tracey
authors.initials: T
authors.lastname: Webster
authors.forename: Ian
authors.initials: I
authors.lastname: Sanne
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D015415:Biomarkers / Q000097:blood; D001823:Body Composition; D015992:Body Mass Index; D003710:Demography; D019587:Dietary Supplements; D017097:Electric Impedance; D002149:Energy Intake; D005260:Female; D015658:HIV Infections / Q000178:diet therapy* / Q000188:drug therapy; D006801:Humans; D008297:Male; D009043:Motor Activity; D010349:Patient Compliance; D010865:Pilot Projects; D015430:Weight Gain
chemical_list: D019380:Anti-HIV Agents; D015415:Biomarkers
references.citation: Health Policy. 2011 Mar;99(3):267-76
references.pmid: 20884072
references.citation: Public Health Nutr. 2012 May;15(5):938-47
references.pmid: 21806867
references.citation: Med Sci Sports Exerc. 2000 Sep;32(9 Suppl):S498-504
references.pmid: 10993420
references.citation: AIDS Patient Care STDS. 2002 Aug;16(8):361-5
references.pmid: 12227986
references.citation: AIDS. 2012 Jun 1;26(9):1161-6
references.pmid: 22472856
references.citation: Clin Nutr. 1999 Dec;18(6):371-4
references.pmid: 10634923
references.citation: J Acquir Immune Defic Syndr. 2008 Oct 1;49(2):190-5
references.pmid: 18769349
references.citation: J Acquir Immune Defic Syndr. 2002 Oct 1;31(2):230-6
references.pmid: 12394802
references.citation: Am J Clin Nutr. 2008 Nov;88(5):1313-21
references.pmid: 18996868
references.citation: J Acquir Immune Defic Syndr Hum Retrovirol. 1998 May 1;18(1):80-5
references.pmid: 9593462
references.citation: J Assoc Nurses AIDS Care. 2005 Mar-Apr;16(2):13-22
references.pmid: 16438122
references.citation: J AIDS Clin Res. 2012;3(7):171
references.pmid: 23227443
references.citation: Clin Infect Dis. 2010 Jul 1;51(1):51-7
references.pmid: 20509768
references.citation: Trop Med Int Health. 2013 Jan;18(1):45-52
references.pmid: 23107420
references.citation: AIDS Care. 2010 Jun;22(6):737-42
references.pmid: 20467944
references.citation: AIDS. 2008 Oct 1;22(15):1897-908
references.pmid: 18784453
references.citation: J Neurovirol. 2012 Jun;18(3):162-71
references.pmid: 22528477
references.citation: Clin Infect Dis. 2011 Nov;53(9):952-60
references.pmid: 21946189
references.citation: Food Nutr Bull. 2010 Dec;31(4):S313-44
references.pmid: 21214036
references.citation: JAMA. 2002 Oct 9;288(14):1728-32
references.pmid: 12365956
references.citation: Food Nutr Bull. 2010 Dec;31(4):S345-64
references.pmid: 21214037
references.citation: Bull World Health Organ. 2008 Sep;86(9):678-87
references.pmid: 18797643
references.citation: World Health Organ Tech Rep Ser. 1995;854:1-452
references.pmid: 8594834
references.citation: Int J Epidemiol. 2013 Apr;42(2):430-9
references.pmid: 22434860
references.citation: Eur J Clin Nutr. 1997 Sep;51(9):637-40
references.pmid: 9306092
references.citation: J Acquir Immune Defic Syndr Hum Retrovirol. 1995 May 1;9(1):20-5
references.pmid: 7712230
references.citation: Am J Clin Nutr. 2010 Apr;91(4):1138S-1142S
references.pmid: 20147470
references.citation: Ig Sanita Pubbl. 2011 Jan-Feb;67(1):41-52
references.pmid: 21468153
references.citation: Clin Infect Dis. 2008 Mar 15;46(6):946-9
references.pmid: 18279043
references.citation: Eur J Clin Nutr. 2001 Dec;55(12):1048-52
references.pmid: 11781670
references.citation: N Engl J Med. 2004 Jul 1;351(1):23-32
references.pmid: 15229304
references.citation: Am J Clin Nutr. 2001 Feb;73(2 Suppl):444S-450S
references.pmid: 11157355
references.citation: Clin Infect Dis. 2009 Sep 1;49(5):787-98
references.pmid: 19624276
references.citation: PLoS One. 2013;8(1):e55544
references.pmid: 23383220
references.citation: Am J Clin Nutr. 2000 Aug;72(2):496-501
references.pmid: 10919947
references.citation: Med Anthropol Q. 2010 Sep;24(3):363-80
references.pmid: 20949841
references.citation: Cochrane Database Syst Rev. 2007 Jul 18;(3):CD004536
references.pmid: 17636766
references.citation: Trop Med Int Health. 2006 Dec;11(12):1849-57
references.pmid: 17176350
references.citation: Nutr J. 2011 Sep 07;10:90
references.pmid: 21899733